Professor Nikolai Petrovsky graduated from Medicine at the University of Tasmania in 1982. He then went on to do his Fellowship specialising in Endocrinology.
Professor Nikolai Petrovsky graduated from Medicine at the University of Tasmania in 1982. He then went on to do his Fellowship specialising in Endocrinology.
Not stopping there, he completed a PhD in Immunology at the Walter & Eliza Hall Institute in Melbourne, one of the world’s leading Immunology research centres.
In addition to being an active clinician, Nikolai is a Professor of Medicine at Flinders University and Chairman and Research director of Vaxine Pty Ltd, an Adelaide-based biotechnology company focused on vaccine development. Over the last 18 years, he has been awarded over $50 million dollars in vaccine research grants including multiple grants from the US government’s National Institutes of Health.
He has authored over 200 peer-reviewed research papers and has won many prestigious awards including Ernst & Young’s Entrepreneur of the Year Award in 2010 and the Asian Executive of the Year award in 2011.
His current focus is completing the development of his company’s protein-based vaccine against COVID-19. This is just entering final Phase 3 clinical trials and is expected to be approved overseas before the end of 2021.
SHDC’s Dr Lewis Ehrlich we keen to talk directly from Professor Petrovsky on two of his Mouthing Off podcast episodes:
Discover more about Dr Lewis’ Mouthing Off Podcast here…